Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

about

Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection.Population pharmacokinetics of intravenous acyclovir in preterm and term infants.

P2860

Q33416429-7D72E796-9D13-4B57-B9A4-27CDED712E74 Q34392526-D32C23AE-C60D-4F0C-AE30-BD822C68342D

P2860

Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

Item

http://www.wikidata.org/entity/Q39782822

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Population pharmacokinetics of ...... orative Antiviral Study Group.

@en

Population pharmacokinetics of ...... orative Antiviral Study Group.

@nl

type

Item

label

Population pharmacokinetics of ...... orative Antiviral Study Group.

@en

Population pharmacokinetics of ...... orative Antiviral Study Group.

@nl

prefLabel

Population pharmacokinetics of ...... orative Antiviral Study Group.

@en

Population pharmacokinetics of ...... orative Antiviral Study Group.

@nl

P1476

Population pharmacokinetics of ...... orative Antiviral Study Group.

@en

P2093

B Britt

http://www.w3.org/2001/XMLSchema#string

G Demmler

http://www.w3.org/2001/XMLSchema#string

J M Trang

http://www.w3.org/2001/XMLSchema#string

J P Sommadossi

http://www.w3.org/2001/XMLSchema#string

M Shelton

http://www.w3.org/2001/XMLSchema#string

P Reuman

http://www.w3.org/2001/XMLSchema#string

R J Whitley

http://www.w3.org/2001/XMLSchema#string

R Jacobs

http://www.w3.org/2001/XMLSchema#string

R Pass

http://www.w3.org/2001/XMLSchema#string

S Adler

http://www.w3.org/2001/XMLSchema#string

P2860

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.

Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.

Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.

Topics in clinical pharmacology: ganciclovir.

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.

Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Simple estimate of creatinine clearance from plasma creatinine in neonates.

Population differences in ganciclovir clearance as determined by nonlinear mixed-effects modelling.

P304

2202-2205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8878608

http://www.w3.org/2001/XMLSchema#string

P921

collaboration

Cytomegalovirus

birth defect

P932

163500

http://www.w3.org/2001/XMLSchema#string

Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

about

P2860

P2860

Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932